$8.26
0.212.61%
After Hours: 9:28 AM EDT
15 minutes delayed
Recursion Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Recursion Pharmaceuticals using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
RXRX | Recursion Pharmaceuticals | -$0.38 | -$0.40 | — | — | $11.02M | $13.75M | — | — | 08/06/2024 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$0.34 | -$0.42 | -$0.39 | 7.14% | $12.13M | $12.65M | $13.49M | 6.65% | 05/09/2024 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$0.31 | -$0.45 | -$0.42 | 6.67% | $13.68M | $20.53M | $10.89M | -46.95% | 02/27/2024 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$0.35 | -$0.38 | -$0.43 | -13.16% | $13.16M | $12.87M | $10.53M | -18.16% | 11/09/2023 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$0.38 | -$0.37 | -$0.38 | -2.70% | $7.67M | $11.91M | $11.02M | -7.50% | 08/08/2023 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$0.33 | -$0.35 | -$0.34 | 2.86% | $5.33M | $14.44M | $12.13M | -15.97% | 05/08/2023 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$0.38 | -$0.29 | -$0.31 | -6.90% | $2.53M | $24.00M | $13.68M | -43.02% | 02/27/2023 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$0.28 | -$0.38 | -$0.35 | 7.89% | $2.53M | $6.97M | $13.16M | 88.81% | 11/08/2022 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$0.31 | -$0.40 | -$0.38 | 5.00% | $2.55M | $5.40M | $7.67M | 42.11% | 08/09/2022 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$1.33 | $0.10 | -$0.33 | -430.00% | $2.56M | $83.95M | $5.33M | -93.65% | 05/10/2022 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$1.17 | -$0.31 | -$0.38 | -22.58% | $2.70M | $6.07M | $2.53M | -58.27% | 03/23/2022 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$1.09 | -$0.28 | -$0.28 | 0.00% | $1.02M | $2.62M | $2.53M | -3.28% | 11/10/2021 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$0.88 | -$0.23 | -$0.31 | -34.78% | — | $2.72M | $2.55M | -6.29% | 08/13/2021 | Get Alert |
RXRX | Recursion Pharmaceuticals | -$0.85 | — | -$1.33 | — | $60.00K | — | $2.56M | — | 05/12/2021 | Get Alert |
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $-0.39 | $-0.42 | 7.14 % |
Dec 2023 | 2024-02-27 | $-0.42 | $-0.45 | 6.67 % |
Sep 2023 | 2023-11-09 | $-0.43 | $-0.38 | -13.2 % |
Jun 2023 | 2023-08-08 | $-0.38 | $-0.37 | -2.70 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-09 | $13.49M | $12.65M | 6.65 % |
Dec 2023 | 2024-02-27 | $10.89M | $20.53M | -46.9 % |
Sep 2023 | 2023-11-09 | $10.53M | $12.87M | -18.2 % |
Jun 2023 | 2023-08-08 | $11.02M | $11.91M | -7.50 % |
Recursion Pharmaceuticals (RXRX) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
The Actual EPS was $-0.39, which beat the estimate of $-0.42.
The Actual Revenue was $13.5M, which beat the estimate of $12.7M.
Browse earnings estimates, EPS, and revenue on all stocks.